Description
Coordination by MEDTEQ+ for the clinical evaluation of novel nasopharyngeal swabs manufactured by Canadian companies for COVID-19 testing,
Amendment chain · 6 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $740,000 at start, $690,000 after amendment #5 (−$50,000).
- #02020-08-15$740,000
- #12021-03-25$740,000
- #22021-06-29$740,000
- #32021-11-23$740,000
- #42022-03-17$740,000
- #52022-10-11$690,000-$50,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2020-08-15(start date) | $740,000 | — | Coordination by MEDTEQ+ for the clinical evaluation of novel nasopharyngeal swabs manufactured by Canadian com… |
| #1 amendment | 2021-03-25 | $740,000 | +$0 | Coordination by MEDTEQ+ for the clinical evaluation of novel nasopharyngeal swabs manufactured by Canadian com… |
| #2 amendment | 2021-06-29 | $740,000 | +$0 | Coordination by MEDTEQ+ for the clinical evaluation of novel nasopharyngeal swabs manufactured by Canadian com… |
| #3 amendment | 2021-11-23 | $740,000 | +$0 | Coordination by MEDTEQ+ for the clinical evaluation of novel nasopharyngeal swabs manufactured by Canadian com… |
| #4 amendment | 2022-03-17 | $740,000 | +$0 | Coordination by MEDTEQ+ for the clinical evaluation of novel nasopharyngeal swabs manufactured by Canadian com… |
| #5 amendment | 2022-10-11 | $690,000 | −$50,000 | Coordination by MEDTEQ+ for the clinical evaluation of novel nasopharyngeal swabs manufactured by Canadian com… |
Related records · 8
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 822206934)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2023-2024-Q2-1009931 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program | $336,541 | FY2024 |
| 172-2020-2021-Q2-954037 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Organizations | $704,000 | FY2021 |
| 172-2019-2020-Q2-932316 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Organizations | $171,500 | FY2020 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Organizations" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q3-1037872 | 1000470559 ONTARIO INC | FY2026 | $12,000 | FY2026 |
| 172-2025-2026-Q3-1037247 | LYNKED INC. | FY2026 | $275,000 | FY2026 |
| 172-2025-2026-Q3-1037368 | Le réseau des centres de transfert de techno. des cégeps du Québec inc. | FY2026 | $200,001 | FY2026 |
| 172-2025-2026-Q3-1035202 | WVenture Entrepreneurial Society | FY2026 | $160,000 | FY2026 |
| 172-2025-2026-Q3-1037002 | CMS Montera Inc. | FY2026 | $75,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2020-2021-Q3-959030 · retrieved 2026-11-13.